Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Roustit M, Jlaiel M, Leclercq P, Stanke-Labesque F.

Br J Clin Pharmacol. 2008 Aug;66(2):179-95. doi: 10.1111/j.1365-2125.2008.03220.x. Review.

2.

Pharmacokinetics of antiretrovirals in pregnant women.

Mirochnick M, Capparelli E.

Clin Pharmacokinet. 2004;43(15):1071-87. Review.

PMID:
15568888
3.

Antiretroviral medications during pregnancy for therapy or prophylaxis.

Stek AM.

Curr HIV/AIDS Rep. 2009 May;6(2):68-76. Review.

PMID:
19358777
4.

Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.

McCormack SA, Best BM.

Clin Pharmacokinet. 2014 Nov;53(11):989-1004. doi: 10.1007/s40262-014-0185-7. Review.

5.
6.

Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.

Senise JF, Castelo A, MartĂ­nez M.

AIDS Rev. 2011 Oct-Dec;13(4):198-213. Review.

PMID:
21975356
7.

[Revised guideline "Antiretroviral Treatment"].

Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren..

Ned Tijdschr Geneeskd. 2005 Oct 22;149(43):2399-405. Review. Dutch.

PMID:
16277129
8.

Pharmacological considerations on the use of antiretrovirals in pregnancy.

Colbers A, Greupink R, Burger D.

Curr Opin Infect Dis. 2013 Dec;26(6):575-88. doi: 10.1097/QCO.0000000000000017. Review.

PMID:
24152762
9.

Delavirdine: a review of its use in HIV infection.

Scott LJ, Perry CM.

Drugs. 2000 Dec;60(6):1411-44. Review.

PMID:
11152019
10.

Antiretroviral therapy in pregnancy: a focus on safety.

Taylor GP, Low-Beer N.

Drug Saf. 2001;24(9):683-702. Review.

PMID:
11522121
11.

Update on antiretroviral therapy.

Riordan A, Bugembe T.

Arch Dis Child. 2009 Jan;94(1):70-4. doi: 10.1136/adc.2007.128744. Review.

PMID:
18838416
12.

Antiretroviral therapy during pregnancy. Beyond AZT (ZDV).

Dattel BJ.

Obstet Gynecol Clin North Am. 1997 Sep;24(3):645-57. Review.

PMID:
9266584
13.

[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2012 Jun;30(6):e1-89. doi: 10.1016/j.eimc.2012.03.006. Spanish.

PMID:
22633764
14.

HIV-1 drug resistance and mother-to-child transmission.

Morris L, Pillay C, Gray G, McIntyre J.

SADJ. 2001 Dec;56(12):614-6. Review.

PMID:
11887450
15.

Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

Kappelhoff BS, Crommentuyn KM, de Maat MM, Mulder JW, Huitema AD, Beijnen JH.

Clin Pharmacokinet. 2004;43(13):845-53. Review.

PMID:
15509183
16.

Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.

Bardsley-Elliot A, Perry CM.

Paediatr Drugs. 2000 Sep-Oct;2(5):373-407. Review.

PMID:
11022799
17.

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Bhana N, Ormrod D, Perry CM, Figgitt DP.

Paediatr Drugs. 2002;4(8):515-53. Review.

PMID:
12126455
18.

Strategies to prevent mother-to-child transmission of HIV.

McIntyre J.

Curr Opin Infect Dis. 2006 Feb;19(1):33-8. Review.

PMID:
16374215
19.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1139-47. doi: 10.3851/IMP1918. Review.

PMID:
22155898
20.

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F; Ghent Group on HIV in Women and Children..

Int J Epidemiol. 2007 Oct;36(5):1009-21. Review.

Items per page

Supplemental Content

Support Center